Vailoces, V.A.S.; Tolentino, A.J.; Arevalo, J.F.; Adelman, R.A.; Bhisitkul, R.; Do, D.V.; Nguyen, Q.D.; Tolentino, M.J.; Tanito, M.; Serizawa, H.
Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration. Pharmaceuticals 2025, 18, 655.
https://doi.org/10.3390/ph18050655
AMA Style
Vailoces VAS, Tolentino AJ, Arevalo JF, Adelman RA, Bhisitkul R, Do DV, Nguyen QD, Tolentino MJ, Tanito M, Serizawa H.
Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration. Pharmaceuticals. 2025; 18(5):655.
https://doi.org/10.3390/ph18050655
Chicago/Turabian Style
Vailoces, Valory Anne S., Andrew J. Tolentino, Jose Fernando Arevalo, Ron A. Adelman, Robert Bhisitkul, Diana V. Do, Quan Dong Nguyen, Michael J. Tolentino, Masaki Tanito, and Hiroaki Serizawa.
2025. "Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration" Pharmaceuticals 18, no. 5: 655.
https://doi.org/10.3390/ph18050655
APA Style
Vailoces, V. A. S., Tolentino, A. J., Arevalo, J. F., Adelman, R. A., Bhisitkul, R., Do, D. V., Nguyen, Q. D., Tolentino, M. J., Tanito, M., & Serizawa, H.
(2025). Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration. Pharmaceuticals, 18(5), 655.
https://doi.org/10.3390/ph18050655